{"id":633745,"date":"2023-01-12T18:40:01","date_gmt":"2023-01-12T18:40:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=633745"},"modified":"2023-01-12T18:40:01","modified_gmt":"2023-01-12T18:40:01","slug":"dengue-fever-market-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-market","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/dengue-fever-market-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-market_633745.html","title":{"rendered":"Dengue Fever Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market"},"content":{"rendered":"
\n
\"Dengue<\/a><\/div>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Dengue Fever Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Dengue Fever, historical and forecasted epidemiology as well as the Dengue Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/div>\n

DelveInsight’s <\/strong>“Dengue Fever Market Insights, Epidemiology, and Market Forecast-2032<\/strong>“<\/a> report delivers an in-depth understanding of the Dengue Fever, historical and forecasted epidemiology as well as the Dengue Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/p>\n

 <\/p>\n

The Dengue Fever market report provides current treatment practices, emerging drugs, Dengue Fever market share of the individual therapies, and current and forecasted Dengue Fever market size from 2019 to 2032 segmented by seven major markets. The Report also covers current Dengue Fever treatment practices\/algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities. It assesses the underlying potential of the market.<\/p>\n

 <\/p>\n

Dengue Fever Overview<\/strong><\/p>\n

Dengue fever is a disease caused by four dengue viruses spread by the Aedes aegypti mosquito. The Centers for Disease Control and Prevention (CDC) estimates that at least 400 million cases of Dengue fever occur across the globe every year. It is also known as breakdown fever due to the severity of muscle spasms and joint pain, and fever, or seven-day fever because of the usual duration of symptoms. It has an incubation period of 5 to 7 days and it follows 3 phases febrile, critical and convulsant.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n

Dengue Fever Epidemiology Insights:<\/strong><\/p>\n